Add to ORKGDistinguishing between driver and passenger mutations in individual cancer genomes by ysi
The complexity of genomic alterations in cancer has made it difficult to identify oncogenic drivers ...
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Cancer genomes conta...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
Revealing selection in cancer using the predicted functional impact of cancer mutations. Application...
Identifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutatio...
Integrated analysis of recurrent properties of cancer genes to identify novel driver
© 2020, The Author(s). The discovery of driver mutations is one of the key motivations for cancer ge...
Somatic mutations in human cancers are comprised of those that contribute to the oncogenic phenotype...
Sporadic cancer develops from the accrual of somatic mutations. Out of all small-scale somatic aberr...
Funder: Province of OntarioThe discovery of driver mutations is one of the key motivations for cance...
MotivationMost approaches used to identify cancer driver genes focus, true to their name, on entire ...
genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge...
Cancers are caused by genomic alterations known as drivers. As drivers have broad applications in pr...
As the genomic profile across cancers varies from person to person, patient prognosis and treatment ...
The complexity of genomic alterations in cancer has made it difficult to identify oncogenic drivers ...
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Cancer genomes conta...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
Revealing selection in cancer using the predicted functional impact of cancer mutations. Application...
Identifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutatio...
Integrated analysis of recurrent properties of cancer genes to identify novel driver
© 2020, The Author(s). The discovery of driver mutations is one of the key motivations for cancer ge...
Somatic mutations in human cancers are comprised of those that contribute to the oncogenic phenotype...
Sporadic cancer develops from the accrual of somatic mutations. Out of all small-scale somatic aberr...
Funder: Province of OntarioThe discovery of driver mutations is one of the key motivations for cance...
MotivationMost approaches used to identify cancer driver genes focus, true to their name, on entire ...
genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge...
Cancers are caused by genomic alterations known as drivers. As drivers have broad applications in pr...
As the genomic profile across cancers varies from person to person, patient prognosis and treatment ...
The complexity of genomic alterations in cancer has made it difficult to identify oncogenic drivers ...
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Cancer genomes conta...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...